Paratek Pharmaceuticals, Inc. Gains 21.08%
Thu, Sep 10, 2020 at 05:30 PM
Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ) soared at $5.63, a gain of 21.1%. On Wed 09 Sep 20, PRTK:NASDAQ hit a New 2-Week Intraday High of $4.9. The stock got featured on our News Catalysts scanner on Wed 09 Sep 20 at 05:19 PM in the 'MISCELLANEOUS' category. From Wed 26 Aug 20, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Wed 29 Jul 20 at $6.41 with a volume of 4M+, and its share price has been moving sideways in recent weeks.
About Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ)
Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics based upon tetracycline chemistry.
Top 10 Gainers:
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 53.79%
- Renren Inc. (RENN:NYSE), 40%
- Pingtan Marine Enterprise Ltd. (PME:NASDAQ), 32.36%
- Novan, Inc. (NOVN:NASDAQ), 27.23%
- QH (QH:NASDAQ), 24.55%
- Virtusa Corporation (VRTU:NASDAQ), 24.49%
- Agenus Inc. (AGEN:NASDAQ), 23.87%
- Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ), 21.08%
- Rhodium (RH:NYSE), 20.05%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 18.49%